This hottest twist while in the Lykos Therapeutics saga threatens A serious overhaul of the corporate’s tactic and direction, with Musk ally and billionaire investor Antonio Gracias showing up to desire to take the company back again towards its nonprofit drug progress roots and a far more Doblinite philosophy.A patent application from psychologi